335 related articles for article (PubMed ID: 9149578)
1. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma.
Kraft M; Wenzel SE; Bettinger CM; Martin RJ
Chest; 1997 May; 111(5):1249-54. PubMed ID: 9149578
[TBL] [Abstract][Full Text] [Related]
2. Potential masking effects of salmeterol on airway inflammation in asthma.
Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
4. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
7. Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma.
Bacci E; Di Franco A; Bartoli ML; Carnevali S; Cianchetti S; Dente FL; Giannini D; Vagaggini B; Ruocco L; Paggiaro PL
Eur Respir J; 2002 Jul; 20(1):66-72. PubMed ID: 12166584
[TBL] [Abstract][Full Text] [Related]
8. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL
Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
[TBL] [Abstract][Full Text] [Related]
10. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.
Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961
[TBL] [Abstract][Full Text] [Related]
12. Partial inhibition of the early and late asthmatic response by a single dose of salmeterol.
Weersink EJ; Aalbers R; Koëter GH; Kauffman HF; De Monchy JG; Postma DS
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1262-7. PubMed ID: 7952550
[TBL] [Abstract][Full Text] [Related]
13. The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma.
Roberts JA; Bradding P; Britten KM; Walls AF; Wilson S; Gratziou C; Holgate ST; Howarth PH
Eur Respir J; 1999 Aug; 14(2):275-82. PubMed ID: 10515401
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
15. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
[TBL] [Abstract][Full Text] [Related]
16. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.
Lockey RF; DuBuske LM; Friedman B; Petrocella V; Cox F; Rickard K
Chest; 1999 Mar; 115(3):666-73. PubMed ID: 10084473
[TBL] [Abstract][Full Text] [Related]
17. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
[TBL] [Abstract][Full Text] [Related]
19. Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids.
Kraft M; Martin RJ; Lazarus SC; Fahy JV; Boushey HA; Lemanske RF; Szefler SJ;
Chest; 2003 Jul; 124(1):42-50. PubMed ID: 12853500
[TBL] [Abstract][Full Text] [Related]
20. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
Currie GP; Syme-Grant NJ; McFarlane LC; Carey FA; Lipworth BJ
Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
